Join the 2025 Joint Transnational Call Webinar on 17 December

The European Rare Diseases Research Alliance (ERDERA) is delighted to invite researchers, patient advocates, and early career professionals to a key webinar on 17 December 2024, following the official launch of the 2025 Joint Transnational Call for Proposals for “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation” on 10 December.

Click here to register for the webinar.

This Webinar will:

  • Provide general information on the call, including its scientific goals, administrative aspects, support services, and patient engagement strategies.
  • Address your questions through two dedicated Q&A sessions.

Agenda (CET)

  • 14.00-14.10  Welcome and Introduction to ERDERA (Daria Julkowska)
  • 14.10-14.30  JTC 2025 Introduction (Ralph Schuster)
  • 14.30-14.40  Pre-clinical therapy development – Evaluators perspective (Christine Kinnon)
  • 14.40-15.00  Q&A – Round 1
  • 15.00-15.10  Patient engagement in research (Roseline Favresse, Avril Kennan)
  • 15.10-15.20  ERDERA expertise support services (Viviana Giannuzzi, Toni Andreu, Rima Nabbout)
  • 15.20-15.30  Data Hub and FAIR data (Marco Roos)
  • 15.30-15.50  Q&A – Round 2
  • 15.50-16.00  Closing remarks

Registration is mandatory

  • The registration deadline is 17 December 2024.
  • Upon submitting your registration, you will receive connection links and calendar invitations to ensure seamless participation.

Note: The webinar will be recorded, and the video recording will be made available exclusively to registered participants.

Don’t miss this chance to get ahead in the application process and ensure that your project stands out!

Find out more details about ERDERA’s Joint Transnational Call 2025 – Preliminary announcement here.

News & Updates

You might also be interested in

Woman helping out a person with a disease

Women’s Day highlights widening gender inequalities in rare diseases

Drawing on Europe-wide patient and carer surveys, ERDERA highlights how gender can shape diagnostic delays, care burden and the evidence base for rare-disease research.
European Parliament Photograph

New European Parliament study maps options for an EU rare disease action plan

European Parliament research service assessment, published in February 2026, identifies 31 measures that could form an EU rare disease action plan, highlighting European Reference Networks and cross-border collaboration including ERDERA as drivers of EU added value.
Rare Disease Day 2026 visual representation

One year of ERDERA: the European alliance built to accelerate rare disease research reports first results

28 February, across Europe and beyond: one year into delivery, ERDERA is advancing towards shorten diagnostic journeys and improved therapies for people living with a rare disease.
Advancement of Treatments for Rare Diseases

Postponed: Advancement of Treatments for Rare Diseases

The two-day event will focus on translating research and policy initiatives into tangible benefits for Rare Disease patients through better prevention, diagnosis, and treatment.

ERDERA's

search form